MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Chorea (also see specific diagnoses, Huntingtons disease, etc): Etiology and Pathogenesis"

  • 2019 International Congress

    Clinical and imaging characteristics of non-manifest LRRK2 and GBA carriers: The PPMI cohort

    A. Siderowf, T. Simuni, L. Uribe, C. Caspell-Garcia, H. Cho, C. Coffey, T. Foroud, B. Mollehauer, C. Tanner, K. Kieburtz, L. Chahine, D. Weintraub, K. Marek (Philadelphia, PA, USA)

    Objective: To examine baseline clinical and dopamine transporter (DAT) imaging characteristics in a cohort of non-manifest carriers (NMC) of GBA and LRRK2 compared to healthy…
  • 2019 International Congress

    Experimental model of developing of Parkinson’s disease

    M. Tukhtamishev, F. Akhmedova (Tashkent, Uzbekistan)

    Objective: Analyzing the reserpine model of Parkinsonian syndrome Background: There are several experimental models of Parkinson's disease: reserpine, methamphetamine, 6-hydroxydopamine (6-OHDA), 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine - substances that…
  • 2019 International Congress

    A Unified Staging System for Prodromal and Manifest Huntington’s disease

    A. Mohan, Z. Sun, S. Ghosh, Y. Li, Y. Cheng, J. Hu, C. Sampaio (Yorktown Heights, NY, USA)

    Objective: To develop an integrated staging methodology for Prodromal and Manifest Huntington’s disease (HD). Background: Once HD is diagnosed clinically (also known as, motor-onset/manifest), HD…
  • 2019 International Congress

    A life-threatening case of Anti-IgLON5 disease

    M. Filidei, N. Tambasco, F. Paolini Paoletti, S. Simoni, E. Brahimi, G. Cappelletti, P. Nigro, P. Calabresi (Perugia, Italy)

    Objective: To present a case of anti-IgLON5 disease with life-threatening respiratory complications. Background: Anti-IgLON5 disease is a little known CNS disorder characterized by non-REM and…
  • 2019 International Congress

    Acute hemichorea in patient of uncontrolled type 2 diabetes mellitus; a case report with characteristic imaging

    M. Salem, A. Helmy, E. Abdeldayem, A. Shalash (Cairo, Egypt)

    Objective: chorea is a rare complication of uncontrolled type 2 diabetes . we report a case of hyperglycemia, due to uncontrolled type 2 diabetes, presented…
  • 2018 International Congress

    Generalized chorea in a patient with isolated leukocytosis and JAK2V617F mutation: A case report

    S. Bette, H. Moore, C. Singer (Miami, FL, USA)

    Objective: To describe late-onset generalized chorea in a patient found to have the JAK2V617F mutation without polycythemia vera. Background: Polycythemia vera (PV) is well-known to…
  • 2018 International Congress

    Elevated serum α-synuclein levels in Huntington’s disease patients

    M. Breza, E. Emmanouilidou, G. Karadima, C.H. Kartanou, M. Panas, K. Vekrellis, G. Koutsis (Athens, Greece)

    Objective: To investigate serum α-synuclein levels in Huntington’s disease (HD) patients. Background: HD is a heredodegenerative disease caused by mutations in HTT coding for huntingtin…
  • 2018 International Congress

    Parallel evaluation of mutant huntingtin and neurofilament light in Huntington’s disease

    L. Byrne, F. Rodrigues, E. Johnson, E. De Vita, C. Czech, S. Schobel, R. Scahill, A. Heslegrave, H. Zetterberg, W. Wild (London, United Kingdom)

    Objective: To assess cerebrospinal fluid (CSF) mutant Huntingtin (mHTT), and CSF and plasma neurofilament light (NfL) in Huntington’s disease (HD). Background: HD is a progressive…
  • 2018 International Congress

    Neurofilament light protein: An emerging clinical and translational biofluid biomarker for Huntington’s disease

    L. Byrne, F. Rodrigues, E. Johnson, S. Gregory, R. Soylu Kucharz, M. Björkqvist, A. Heslegrave, K. Blennow, A. Durr, B. Leavitt, R. Roos, S. Tabrizi, H. Zetterberg, D. Langbehn, R. Scahill, E. Wild (London, United Kingdom)

    Objective: To investigate whether neurofilament light protein (NfL) a potential prognostic marker of neurodegeneration with Huntington’s disease. Background: NfL, a component of the axonal cytoskeleton,…
  • 2018 International Congress

    Neuroprotective role of cinnamaldehyde against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington’s disease

    P. Kashyap, S. Gupta (Bihar, India)

    Objective: The present study examined the potential therapeutic effects of CA against 3-nitropropionic acid (3-NP)-induced oxidative stress in a rat model of HD and explored…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley